z-logo
open-access-imgOpen Access
Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease
Author(s) -
KuangChun Hu,
HorngYuan Wang,
Sung-Chen Liu,
Chuan-Chuan Liu,
ChungLieh Hung,
MingJong Bair,
ChunJen Liu,
Ming–Shiang Wu,
ShouChuan Shih
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i24.7718
Subject(s) - medicine , nonalcoholic fatty liver disease , cirrhosis , liver biopsy , fatty liver , gastroenterology , hepatocellular carcinoma , chronic liver disease , population , steatohepatitis , disease , metabolic syndrome , obesity , liver disease , diabetes mellitus , gold standard (test) , biopsy , pathology , endocrinology , environmental health
Nonalcoholic fatty liver disease (NAFLD) refers to the accumulation of fat (mainly triglycerides) within hepatocytes. Approximately 20%-30% of adults in the general population in developed countries have NAFLD; this trend is increasing because of the pandemicity of obesity and diabetes, and is becoming a serious public health burden. Twenty percent of individuals with NAFLD develop chronic hepatic inflammation [nonalcoholic steatohepatitis (NASH)], which can be associated with the development of cirrhosis, portal hypertension, and hepatocellular carcinoma in a minority of patients. And thus, the detection and diagnosis of NAFLD is important for general practitioners. Liver biopsy is the gold standard for diagnosing NAFLD and confirming the presence of NASH. However, the invasiveness of this procedure limits its application to screening the general population or patients with contraindications for liver biopsy. The development of noninvasive diagnostic methods for NAFLD is of paramount importance. This review focuses on the updates of noninvasive diagnosis of NAFLD. Besides, we review clinical evidence supporting a strong association between NAFLD and the risk of cardiovascular disease because of the cross link between these two disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here